000 01293 a2200361 4500
005 20250511202743.0
264 0 _c19920115
008 199201s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00686332
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, M M
245 0 0 _aThe relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1991
300 _a29-32 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCisplatin
_xanalogs & derivatives
650 0 4 _aCreatinine
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHydrolysis
650 0 4 _aKidney
_xchemistry
650 0 4 _aMetabolic Clearance Rate
_xdrug effects
650 0 4 _aPlatinum
_xanalysis
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
700 1 _aBasinger, M A
700 1 _aBeaty, J A
700 1 _aHolscher, M A
773 0 _tCancer chemotherapy and pharmacology
_gvol. 29
_gno. 1
_gp. 29-32
856 4 0 _uhttps://doi.org/10.1007/BF00686332
_zAvailable from publisher's website
999 _c1749240
_d1749240